MetaADEDB 2.0 @ LMMD
Clenbuterol
(STJMRWALKKWQGH-UHFFFAOYSA-N)
Structure
SMILES
OC(c1cc(Cl)c(c(c1)Cl)N)CNC(C)(C)C
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
R03AC14; R03CC13; R03CC63
Molecular Formula:
C12H18Cl2N2O
Molecular Weight:
277.190
Log P:
3.9692
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
3
TPSA:
58.28
CAS Number(s):
37148-27-9; 50499-60-0
Synonym(s)
1.
Clenbuterol
2.
NAB-365
3.
Planipart
4.
NAB 365
5.
NAB365
External Link(s)
MeSHD002976
PubChem Compound2783
BindingDB27958
ChEBI174690
CHEMBLCHEMBL49080
DrugBankDB01407
DrugCentral673
KEGGdr:D07713
Therapeutic Target DatabaseD0X5NX
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood creatine phosphokinase increasedFAERS: 1US FAERS
2Blood potassium decreasedFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
3Chest PainFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
4Drug toxicityFAERS: 1US FAERS
5MalaiseFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
6MyalgiaFAERS: 1US FAERS
7PainFAERS: 1US FAERS
8TachycardiaFAERS: 1US FAERS
9TremorFAERS: 1
Canada Vigilance: 1		3907640CTD
Canada Vigilance
US FAERS
10Troponin increasedFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
11Alanine Aminotransferase IncreasedOFFSIDES
12Altered state of consciousnessOFFSIDES
13AnorexiaOFFSIDES
14AnosmiaOFFSIDES
15Anticholinergic SyndromeOFFSIDES
16AsthmaOFFSIDES
17BlepharoptosisOFFSIDES
18Blood alkaline phosphatase increasedOFFSIDES
19Blood creatine increasedCanada Vigilance: 1Canada Vigilance
20Blood glucose decreasedOFFSIDES
21Blood lactate dehydrogenase increasedOFFSIDES
22Blood potassium increasedOFFSIDES
23Blood uric acidOFFSIDES
24Cancer PainOFFSIDES
25Chemotherapeutic drug level increasedOFFSIDES
26ClonusCanada Vigilance: 1Canada Vigilance
27Disease recurrenceOFFSIDES
28Dyskinesia, Drug-Induced1742751CTD
29DyslaliaOFFSIDES
30EmpyemaOFFSIDES
31ErythropeniaOFFSIDES
32FlushingCanada Vigilance: 1Canada Vigilance
33Gamma-Glutamyltransferase IncreasedOFFSIDES
34Leukocyte alkaline phosphatase increasedOFFSIDES
35Leukopenia neonatalOFFSIDES
36Liver Failure15021963CTD
37Muscular Atrophy1351811CTD
38Myocardial Infarction9715231CTD
39Myocardial Reperfusion Injury20590644CTD
40PalpitationsCanada Vigilance: 1Canada Vigilance
41Pharmaceutical product complaintOFFSIDES
42Prescribed overdoseOFFSIDES
43Pulmonary InfarctionOFFSIDES
44Pustular psoriasisOFFSIDES
45Status EpilepticusOFFSIDES
46Subcorneal pustular dermatosisOFFSIDES
47Sudden deathOFFSIDES
48TinnitusCanada Vigilance: 1Canada Vigilance
49Ventricular FibrillationOFFSIDES
50VomitingCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.